KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Cash from Financing Activities (2016 - 2025)

NovoCure (NVCR) has disclosed Cash from Financing Activities for 12 consecutive years, with -$559.5 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 20937.77% to -$559.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$451.3 million through Dec 2025, down 599.74% year-over-year, with the annual reading at -$451.3 million for FY2025, 599.74% down from the prior year.
  • Cash from Financing Activities hit -$559.5 million in Q4 2025 for NovoCure, down from $100.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $100.5 million in Q3 2025 to a low of -$559.5 million in Q4 2025.
  • Historically, Cash from Financing Activities has averaged -$15.2 million across 5 years, with a median of $3.5 million in 2021.
  • Biggest YoY gain for Cash from Financing Activities was 100417.0% in 2025; the steepest drop was 20937.77% in 2025.
  • Year by year, Cash from Financing Activities stood at $3.7 million in 2021, then dropped by 6.63% to $3.4 million in 2022, then crashed by 43.99% to $1.9 million in 2023, then surged by 40.58% to $2.7 million in 2024, then crashed by 20937.77% to -$559.5 million in 2025.
  • Business Quant data shows Cash from Financing Activities for NVCR at -$559.5 million in Q4 2025, $100.5 million in Q3 2025, and $2.4 million in Q2 2025.